Alexion Pharmaceuticals Company Profile

Aggregated data from the web about Alexion Pharmaceuticals

Company Name	Alexion Pharmaceuticals
Website	https://alexion.com
Snippet	Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.
ISIN	US0153511094
Type	Public
Founded	1992
Founder	Leonard Bell
Revenue	US$3,551.1 million (2017)
Website	www.alxn.com
Industry	Pharmaceutical
Products	Soliris
Traded as	NASDAQ: ALXN, NASDAQ-100 component, S&P 500 component
Key people	Leonard Bell (Chairman)Ludwig N. Hantson (CEO)
Net income	US$443.3 million (2017)
Headquarters	Boston, Massachusetts, U.S.
Total assets	US$13,583.3 million (2017)
Total equity	US$8,893.1 million (2017)
Operating income	US$627.4 million (2017)
Number of employees	2,525 (2017)

Alexion Pharmaceuticals is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.